Search results
Results from the WOW.Com Content Network
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. [16] Lisdexamfetamine is taken by mouth. Its effects generally begin within two hours ...
The number of new psychiatric drugs, and especially antidepressants on the market in Japan, is significantly less than Western countries. [1]One of the biggest barriers to antidepressants coming to the market is that the medical insurance system in Japan is national, and the authorities are keen to contain a potentially explosive market for drugs like antidepressants that, from the Japanese ...
The Drug Enforcement Administration is increasing the production limit of Vyvanse and its generic equivalents by about 24% to address the ongoing global shortage of ADHD medications.
The FDA approved the generic version of Vyvanse for the first time in August 2023. In the few months since its approval, fills have surged, outnumbering those for brand name Vyvanse, per GoodRx data .
Since then, doctors say other ADHD medications, such as Focalin, Ritalin and Vyvanse, have become in short supply. As of 2022, there were 107 U.S. companies involved in manufacturing ADHD drugs, ...
The illegal drug trade in Japan is the illegal production, ... Illegal drug trafficking cases increased by 10 percent to 326 in 2011 compared with 2010. About 509 ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Controlled Substances; Long title: An Act to amend the Public Health Service Act and other laws to provide increased research into, and prevention of, drug abuse and drug dependence; to provide for treatment and rehabilitation of drug abusers and drug dependent persons; and to strengthen existing law enforcement authority in the field of drug abuse.